Supplementary material:
Table S1: Descriptive analysis of age in the population screened for M. genitalium study and CT/NG screening (provincial report 2019):
Total Male Female
Mean Median Min Max Mean Median Min Max Mean Median Min Max
MG POS 26.8 25 15 74 31.6 29 18 74 25.5 24 15 46
MG NEG 30.4 29 3 86 33.8 31 14 86 28.9 28 3 84
MG TOTAL 30.1 28 3 86 33.6 31 14 86 28.5 27 3 84
CT POS 25.16 23.17 0.04 73.08 26.95 24.84 4.03 73.13 24.07 22.28 0.04 63.00 CT NEG 31.17 29.24 0.00 96.93 34.12 31.33 0.00 96.61 29.79 28.47 0.00 96.93 NG POS 28.21 26.79 0.00 80.29 30.79 29.00 8.01 80.29 26.00 25.25 0.00 60.57 NG NEG 30.84 28.88 0.00 96.93 33.68 30.86 0.00 96.61 29.51 28.16 0.00 96.93 CT/NG TOTAL 30.77 28.82 0.00 96.93 33.56 30.77 0.00 96.61 29.44 28.09 0.00 96.93
Figure S1: The Mann-Whitney U test showed a significant difference (p<0.001) in the age distribution between M. genitalium positive (mean age= 26.77) and negative (mean age= 30.43) Aptima urine specimens.
Figure S2: Age distribution of population screened for this study categorized by gender.
Supplementary references:
31s. Le Roy C, Pereyre S, Hénin N, et al. French prospective clinical evaluation of the Aptima Mycoplasma genitalium CE-IVD assay and macrolide resistance detection using three distinct assays. J Clin Microbiol 2017; 55:3194-3200.
32s. Hokynar K, Hiltunen-Back E, Mannonen L, et al. Prevalence of Mycoplasma genitalium and mutations associated with macrolide and fluoroquinolone resistance in Finland. Int J STD AIDS 2018; 29:904-907.
33s. Upton A, Bissessor L, Lowe P, et al. Diagnosis of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Mycoplasma genitalium: an observational study of testing patterns, prevalence and co-infection rates in northern New Zealand. Sex Health 2018;
15:232-237.
34s. Pond MJ, Nori AV, Witney AA et al. High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options. Clin Infect Dis 2014; 58:631-637.
35s. Lau A, Bradshaw CS, Lewis D, et al. The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis. Clin Infect Dis 2015;
61:389-399.
36s. Huppert JS, Mortensen JE, Reed JL, et al. Mycoplasma genitalium detected by transcription-mediated amplification is associated with Chlamydia trachomatis in adolescent women. Sex Transm Dis 2008; 35:25-254.
37s. Lau A, Bradshaw CS, Lewis D, et al. The efficacy of azithromycin for the treatment of genital Mycoplasma genitalium: a systematic review and meta-analysis. Clin Infect Dis 2015;
61:1389-1399.
38s. Chrisment D, Charron A, Cazanave C, et al. Detection of macrolide resistance in Mycoplasma genitalium in France. J Antimicrob Chemo. 2012; 67:2598-601.
39s. Bissessor M, Tabrizi SN, Twin J, et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium–infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis. 2015; 60:1228-36.
40s. Machalek DA, Tao Y, Shilling H, et al. Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta- analysis. Lancet Infect Dis 2020; 20:30154-30157.
41s. Durukan D, Read TR, Murray G, et al. Resistance-guided antimicrobial therapy using doxycycline–moxifloxacin and doxycycline–2.5 g azithromycin for the treatment of Mycoplasma genitalium infection: efficacy and tolerability. Clin Infect Dis 2019; ciz1031:1-8.
42s. Bachmann LH, Kirkcaldy RD, Geisler WM, et al. Prevalence of Mycoplasma genitalium infection, antimicrobial resistance mutations and symptom resolution following treatment of urethritis. Clin Infect Dis 2020; ciaa293:1-9.
43s. Hamasuna R, Le PT, Kutsuna S, et al. Mutations in ParC and GyrA of moxifloxacin- resistant and susceptible Mycoplasma genitalium strains. PLoS One 2018; 13: e0198355.
44s. Bradshaw CS, Jensen JS, Waites KB. New horizons in Mycoplasma genitalium treatment.
J Infect Dis 2017; 216:S412-9.
45s. Deguchi T, Ito S, Yasuda M, et al. Emergence of Mycoplasma genitalium with clinically significant fluoroquinolone resistance conferred by amino acid changes both in GyrA and ParC in Japan. J Infect Chemother 2017; 23:648-650.
46s. Glaser AM, Geisler WM, Ratliff AE, et al. Two cases of multidrug-resistant genitourinary Mycoplasma genitalium infection successfully eradicated with minocycline. Int J STD AIDS 2019;
30:512-514.
47s. Braam JF, van Dommelen L, Henquet CJ, et al. Multidrug-resistant Mycoplasma genitalium infections in Europe. Eur J Clin Microbiol Infect Dis 2017; 36:1565-1567.
48s. Read TR, Jensen JS, Fairley CK, et al. Use of pristinamycin for macrolide-resistant Mycoplasma genitalium infection. Emerg Infect Dis 2018; 24:328.
49s. Fifer HS, Saunders J, Soni S, et al. British Association for Sexual Health and HIV national guideline for the management of infection with Neisseria gonorrhoeae (2019). UK: BASHH.
2019;25.
50s. Cyr SS. Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020. MMWR.
Morbidity and Mortality Weekly Report. 2020;69.
51s. Gottesman T, Yossepowitch O, Samra Z, et al. Prevalence of Mycoplasma genitalium in men with urethritis and in high risk asymptomatic males in Tel Aviv: a prospective study. Int J STD AIDS 2017; 28:127-132.
52s. Black V, Magooa P, Radebe F, et al. The detection of urethritis pathogens among patients with the male urethritis syndrome, genital ulcer syndrome and HIV voluntary counselling and testing clients: should South Africa’s syndromic management approach be revised?. Sex Transm Infect 2008; 84:254-258.
53s. Jensen JS, BjÖrnelius E, Dohn B, et al. Comparison of first void urine and urogenital swab specimens for detection of Mycoplasma genitalium and Chlamydia trachomatis by polymerase chain reaction in patients attending a sexually transmitted disease clinic. Sex Transm Dis 2004;
31:499-507.
54s. Salado-Rasmussen K, Jensen JS. Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. Clin Infect Dis 2014; 59:24-30.
55s. Cohen CR, Nosek M, Meier A, et al. Mycoplasma genitalium infection and persistence in a cohort of female sex workers in Nairobi, Kenya. Sex Transm Dis 2007; 34:274-279.